Tamsulosin Contraindications in Patients With Glaucoma History
Tamsulosin is not contraindicated solely on the basis of a history of glaucoma. [1] The primary ophthalmic safety concern is intraoperative floppy iris syndrome (IFIS) during cataract and glaucoma surgery, which requires ophthalmology notification. [1]
FDA-Label Contraindication Criteria
The FDA labeling for tamsulosin lists contraindication only for known hypersensitivity to tamsulosin or any component of the product. [1] A history of glaucoma is not included in the contraindications section. [1]
Ophthalmic Warning Linked to Cataract or Glaucoma Surgery
IFIS has been observed during cataract and glaucoma surgery in some patients taking or previously treated with alpha-1 blockers, including tamsulosin. [1] Patients considering cataract or glaucoma surgery should be advised to tell the ophthalmologist that tamsulosin has been taken. [1] Initiation of tamsulosin therapy in patients for whom cataract or glaucoma surgery is scheduled is not recommended. [1]
Clinical Implication for Patients With Prior Glaucoma
Prior glaucoma history should be treated as an ophthalmology-relevant risk factor for surgical planning rather than a medication contraindication. [1] IFIS prevention focuses on communication with the operating ophthalmology team and surgical preparation for possible small pupil behavior. [1]
Key Patient-Safety Practice
Tamsulosin history should be documented before cataract or glaucoma surgery to enable intraoperative risk mitigation for IFIS. [1]
Evidence Base for IFIS Risk (Medication Class Effect)
IFIS is described as a known complication associated with alpha-1 blocker therapy during eye surgery, with tamsulosin specifically included in the product labeling warning. [1] The labeling does not restrict use based on glaucoma history alone. [1]